Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 88 microgram - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; sodium stearylfumarate; light magnesium oxide; indigo carmine aluminium lake; tartrazine aluminium lake - levothyroxine astron is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine astron is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 88 microgram - tablet, uncoated - excipient ingredients: microcrystalline cellulose; light magnesium oxide; sodium starch glycollate; sodium stearylfumarate; indigo carmine aluminium lake; tartrazine aluminium lake - levothyroxine intas is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine intas is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 88 microgram - tablet, uncoated - excipient ingredients: sodium stearylfumarate; sodium starch glycollate; light magnesium oxide; microcrystalline cellulose; indigo carmine aluminium lake; tartrazine aluminium lake - levothyroxine intas is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine intas is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 88 microgram - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium stearylfumarate; sodium starch glycollate; light magnesium oxide; indigo carmine aluminium lake; tartrazine aluminium lake - levothyroxine astron is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine astron is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.125 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.05 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.